Tzali Cnaani has a proven track record in all facets of leading R&D and businesses, from inception to fund raising, product strategy,operations and sales management. Previously, Mr. Cnaani was CEO of Lumitest, which developed a unique medical device to measure oxidative stress in biological fluids, establishing the technology through cooperation with medical centers and academia. Prior to that, he was CEO of SAE Afikim (Afimilk), a world leader in computerized dairy management systems. Mr. Cnaani was EVP and member of the board of directors of Gambit Computer Communication. He holds a B.Sc. degree in physics from the Technion Israel Institute of Technology.
Dr. Sergei Shnizer is the inventor of TCL technology and the first to apply it to medicine. Specializing in Anesthesiology and Intensive Care Medicine, he developed an interest in the effect and mechanisms of free radicals in critically ill patients. Dr. Shnizer was also a co-founder of SPM Ltd. (now OZ Recovery Technologies), which developed a device for treatment of diabetes wounds using ozone. Prior to immigrating to Israel, he spent 15 years at Botkin Hospital in Moscow in the Department of Emergency Medicine and Hyperbaric Oxygen as Senior Physician. Dr. Shnizer’s Ph.D. thesis covered “Using Free Radical Activity Tests in Intensive Care Units.” He has published over 30 articles in peer-reviewed journals.
Mr. Shavit is an accomplished Senior Technology Executive with a proven track record for building, leading, and commercializing world-class medical devices. He has held positions as VP of R&D at ThermoGenesis Corp. (California, USA), MediVision, SAE Afikim, Trig Medical, and AFP Imaging, and has been responsible forproduct development and commercialization. Mr. Shavit earned his M.Sc. and B.Sc. degrees in electronics from the Poly-NYU University and is a co-author of several patents in medical devices and imaging and in telecommunication systems.